1. Home
  2. DAIO vs MIRA Comparison

DAIO vs MIRA Comparison

Compare DAIO & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Data I/O Corporation

DAIO

Data I/O Corporation

N/A

Current Price

$3.91

Market Cap

37.9M

Sector

Industrials

ML Signal

N/A

Logo MIRA Pharmaceuticals Inc.

MIRA

MIRA Pharmaceuticals Inc.

HOLD

Current Price

$0.93

Market Cap

43.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAIO
MIRA
Founded
1969
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
37.9M
43.7M
IPO Year
1995
2023

Fundamental Metrics

Financial Performance
Metric
DAIO
MIRA
Price
$3.91
$0.93
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$5.22
N/A
AVG Volume (30 Days)
64.5K
84.0K
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$21,500,000.00
N/A
Revenue This Year
$4.51
N/A
Revenue Next Year
$30.29
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.16
$0.90
52 Week High
$4.49
$2.45

Technical Indicators

Market Signals
Indicator
DAIO
MIRA
Relative Strength Index (RSI) 56.16 46.20
Support Level $2.98 $0.92
Resistance Level $4.10 $1.22
Average True Range (ATR) 0.21 0.04
MACD -0.03 0.00
Stochastic Oscillator 52.94 41.94

Price Performance

Historical Comparison
DAIO
MIRA

About DAIO Data I/O Corporation

Data I/O Corp provides semiconductor programming, security provisioning, and intellectual property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices and secure microcontrollers. It operates as a single segment entity, with the sole objective to design, manufacture, and sell programming solutions and Programming-as-a-Service (PaaS) to the world's various electronics manufacturers including OEMs, CMs and EMS companies. The company operate in three separate locations Redmond, Washington; Shanghai, China; and Munich, Germany.

About MIRA MIRA Pharmaceuticals Inc.

Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.

Share on Social Networks: